BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1925814)

  • 21. [ACE-inhibitors and cardiovascular protection].
    Agabiti-Rosei E; Muiesan ML
    Cardiologia; 1994 Dec; 39(12 Suppl 1):139-47. PubMed ID: 7634257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of indapamide and hydrochlorothiazide on cardiac hypertrophy and vascular smooth-muscle phenotype in the stroke-prone, spontaneously hypertensive rat.
    Contard F; Glukhova M; Sabri A; Marotte F; Sartore S; Narcisse G; Schatz C; Guez D; Rappaport L; Samuel JL
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S29-34. PubMed ID: 7508058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Angiotensin converting enzyme inhibitors in arterial hypertension].
    Ramón González-Juanatey J
    Rev Esp Cardiol; 1999; 52 Suppl 3():73-8. PubMed ID: 10614152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension.
    Clozel JP; Kuhn H; Hefti F
    J Hypertens; 1989 Apr; 7(4):267-75. PubMed ID: 2524524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular remodeling: the role of angiotensin-converting enzyme inhibitors.
    Chrysant SG
    Am Heart J; 1998 Feb; 135(2 Pt 2):S21-30. PubMed ID: 9488609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting enzyme inhibitors and effects on left ventricular hypertrophy.
    Dahlöf B
    Blood Press Suppl; 1994; 2():35-40. PubMed ID: 8061844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
    Guidi E; Hollenberg NK
    J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute effects of angiotensin-converting enzyme inhibition on coronary vasomotion in hypertensive patients.
    Nitenberg A; Antony I
    Eur Heart J; 1998 Sep; 19 Suppl J():J45-51. PubMed ID: 9796840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac effects of ACE inhibition.
    Lund-Johansen P; Omvik P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S36-40. PubMed ID: 7507538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The renin-angiotensin system and vascular hypertrophy.
    Rosendorff C
    J Am Coll Cardiol; 1996 Oct; 28(4):803-12. PubMed ID: 8837552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arterial effects of angiotensin converting enzyme inhibition in renovascular and spontaneously hypertensive rats.
    Levy BI; Michel JB; Salzmann JL; Azizi M; Poitevin P; Camilleri JP; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S23-5. PubMed ID: 3225686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of structural changes in hypertensive--a major prospect for the future?
    Rosendorff C
    S Afr Med J; 1991 Aug; 80(3):121-2. PubMed ID: 1862442
    [No Abstract]   [Full Text] [Related]  

  • 33. The development and regression of vascular hypertrophy.
    Mulvany MJ
    J Cardiovasc Pharmacol; 1992; 19 Suppl 2():S22-7. PubMed ID: 1377300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large artery dilation produced by converting enzyme inhibition in hypertension: therapeutic aspects.
    Safar ME; Asmar RG; Benetos A
    Am J Med; 1992 Apr; 92(4B):47S-53S. PubMed ID: 1580280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in arterial distensibility produced by converting enzyme inhibitors in hypertensive humans.
    Safar ME; London GM; Safavian A; St Laurent ; Pannier B
    Clin Exp Hypertens A; 1987; 9(2-3):289-95. PubMed ID: 3038389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical denervation does not affect the medial hypertrophy and increased calcium sensitivity of mesenteric resistance vessels from spontaneously hypertensive rats.
    Mulvany MJ; Korsgaard N; Nyborg N; Nilsson H
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():61s-63s. PubMed ID: 7318358
    [No Abstract]   [Full Text] [Related]  

  • 37. Regional heterogeneity of arterial structural changes.
    Daemen MJ; De Mey JG
    Hypertension; 1995 Apr; 25(4 Pt 1):464-73. PubMed ID: 7721385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural adaptation of the cardiovascular system in hypertension. Hemodynamic consequences of vascular wall hypertrophy.
    Sivertsson R
    Nephron; 1987; 47 Suppl 1():71-5. PubMed ID: 3696354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperplasia of rat arteries smooth muscle cells associated with development and reversal of renal hypertension.
    Rorive GL; Carlier PJ; Foidart JM
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():335s-338s. PubMed ID: 7449280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-induced modification of vascular structure: effects of antihypertensive drugs.
    Schachter M
    Am Heart J; 1991 Jul; 122(1 Pt 2):316-23. PubMed ID: 2053552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.